<div class="raw-html-embed"><a href="https://staempflirecht.ch/studium">JUS-Studium? Das Fachwissen von Expertinnen und Experten des Schweizer Rechts – griffbereit!</a></div>

Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Aboverträge Kündigen

Résiliation d’abonnement

Vertrag widerrufen

Résiliation de contrat 

Datenschutz

Protection des données

Impressum

Mentions légales

Barrierefreiheit

Accessibilité

Zahlung und Lieferung

Paiement et livraison

Libra

Was ist Libra?

C'est quoi Libra ?

Kostenlos testen

Tester gratuitement

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Aktienrecht

Droit des sociétés anonymes

Publikationen

Publications

Literatur

Digitales Angebot

Bücher

Livres

Buchreihen

Collections

Onlinemodule LEXIA

Modules en ligne LEXIA

recht.ch

Studienliteratur

Littérature pour les études

Swisslex

Dienstleistungen

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Open Access Policy

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Unser Magazin

Notre magazine

Vision und Mission

Vision et mission

Partner

Partenaires

Unternehmenskultur

Culture d'entreprise

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Sortiment & Suche

Catalogue & Recherche

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

Fachkatalog Recht

Catalogue de droit

How Big Pharma failed to end a pandemic, and what it tells us about the global economy

How Big Pharma failed to end a pandemic, and what it tells us about the global economy

Dearden N: Pharmanomics

Pharmanomics

How Big Pharma Destroys Global Health

Introduction: Bad Apples 1. A History of Scandal 2. A Hedge Fund with a Pharmaceutical Firm Attached 3. It Was Greed, My Friends 4. The Pandemic Begins 5. Recolonising the Global Economy 6. The Hospital That Became a Trading Floor 7. A New Hope 8. Reach for the Moon

Essentials

Dieses Essential richtet sich an Führungskräfte in Gesundheitseinrichtungen, die sich mit zukunftsorientiertem Management auseinandersetzen möchten, um Nachhaltigkeit in ihre Organisation zu integrieren. Es verbindet Grundlagenwissen mit praxisnahen Impulsen zur Implementierung ökologischer, sozialer und ökonomischer Ziele in die Unternehmensführung. Im Fokus steht die Transformation hin zu einer nachhaltigen Organisationskultur – für gesunde, motivierte und leistungsfähige Mitarbeitende.Der Inhalt<ul><li>Nachhaltige Führung und Unternehmenskultur</li><li>Kennzeichen nachhaltig geführter Organisationen</li><li>Prinzipien gesundheitskompetenter Führung</li><li>Bausteine nachhaltiger Gesundheit</li><li>Praxishinweise zur Umsetzung</li></ul>&nbsp;Die AutorinDr. Christine von Reibnitz
 , Gesundheitswissenschaftlerin, Professorin für Gesundheitsmanagement und Hochschullehrerin verschiedener Bachelor- und Masterstudiengänge der ISM (International School of Management) und Medizinischen Paracelsus Universität Salzburg, Fachbuchautorin.

Nachhaltige Führung in Gesundheitseinrichtungen

This open access book argues that the scarcity created by the under-production of vaccines during the Covid-19 years was an entirely predictable, even legitimate consequence of how the international patent system works. Far from being a technical sub-discipline of intellectual property law that simply protects inventions, the international patent system is prismatic of the ways in which we fail to adapt to the challenges of our times: patent rights are intended to incentivise innovation for societal benefit, but in fact facilitate predictable injustice. The patent system ignores the care-constituted nature of our lives, prioritising limiting notions of fairness at the cost of structural harms. The Social Life of Intellectual Property proposes an ethic of just care to temper justice in the global governance of technology. It explores intellectual property as recurring social processes and explains why individual agency and shared responsibility are implicated. On an ecologically imperilled planet, and in a time between pandemics, we must reckon with what we are socialised to believe is legally possible. The ebook editions of this book are available open access under a CC BY-NC-ND 4.0 licence on bloomsburycollections.com.

Justice, Patents, and Care

The Social Life of Intellectual Property

Previously known as Drafting Agreements in the Biotechnology and Pharmaceutical Industries, this title provides precedent agreements for the main types of commercial transaction encountered in the life sciences, biotechnology and pharmaceutical industries. In addition to the print version, each precedent is available via an accompanying website in a format which can be easily downloaded and edited. Detailed commentary on legal, commercial and practice issues accompanies every precedent. Provided by specialist lawyers from across Europe, this commentary also highlights important differences between English law and that of other key EU jurisdictions: Germany, France, the Netherlands, Spain and Sweden. Commentary on specific considerations for the US is also provided. In addition to precedent commentaries, the book also contains detailed commentary and discussion of legal issues common to the life sciences, biotechnology and pharmaceutical industries, as well as links to relevant materials (eg regulatory materials on clinical trials). This title is included in Bloomsbury Professional's Intellectual Property and IT online service.

Drafting Agreements in Life Sciences

Das Buch behandelt das umfangreiche Gebiet der Medizin in einigen Schwerpunktthemen und weist auf ökonomische Zusammenhänge zu diesen Themen hin.&nbsp;Die Notwendigkeit, medizinische mit ökonomischer Forschung und Lehre zu verknüpfen, wird nicht mehr in Frage gestellt, da die Kosten im Gesundheitswesen ausufern. Ein aktuelles Beispiel für überproportional steigende Kosten im Gesundheitswesen sind die Ausgaben für Medikamente, die stärker zunehmen als das Bruttoinlandsprodukt (BIP). Die Kostendiskussion muss daher weiter auf allen Ebenen des Gesundheitswesens vom niedergelassenen Arzt bis zum Krankenhaus, von der pharmazeutischen Industrie bis zu den Spitzenverbänden der Selbstverwaltung geführt werden, da die wirtschaftlichen Konsequenzen einer rationalen medizinischen Versorgung analysiert, kritisch diskutiert, bewertet und transparent dargestellt werden müssen.&nbsp;Es fehlt bisher ein Basislehrbuch der Medizin für Ökonomen, also ein Buch, das medizinische Inhalte auf das für Gesundheitsökonomen relevante Maß begrenzt und dabei versucht, medizinische Maßnahmen im Zusammenhang mit Kostenbewertungen zu veranschaulichen.&nbsp;Das wesentliche Anliegen des vorliegenden Buches ist daher die Verbindung ärztlichen Denkens und Handelns mit ökonomischen Überlegungen, da der Dialog zwischen Ökonomen und Mediziner nur auf der Basis gemeinsamen Wissens effizient geführt werden kann.
 Über den AutorProf. Dr. med. Helmut Brunner
 ist&nbsp;Facharzt für Mikrobiologie und Infektionsepidemiologie, außerplanmäßiger Professor an der Universität Düsseldorf,&nbsp;Lehrbeauftragter an der Universität Wuppertal im Studiengang Gesundheitsökonomie und Gesundheitsmanagement sowie Gutachter für IT-Anwendungen im Gesundheitswesen.

Das Buch behandelt das umfangreiche Gebiet der Medizin in einigen Schwerpunktthemen und weist auf ökonomische Zusammenhänge zu diesen Themen hin.&nbsp;Die Notwendigkeit, medizinische mit ökonomischer Forschung und Lehre zu verknüpfen, wird nicht mehr in Frage gestellt, da die Kosten im Gesundheitswesen ausufern. Ein aktuelles Beispiel für überproportional steigende Kosten im Gesundheitswesen sind die Ausgaben für Medikamente, die stärker zunehmen als das Bruttoinlandsprodukt (BIP). Die Kostendiskussion muss daher weiter auf allen Ebenen des Gesundheitswesens vom niedergelassenen Arzt bis zum Krankenhaus, von der pharmazeutischen Industrie bis zu den Spitzenverbänden der Selbstverwaltung geführt werden, da die wirtschaftlichen Konsequenzen einer rationalen medizinischen Versorgung analysiert, kritisch diskutiert, bewertet und transparent dargestellt werden müssen.&nbsp;Es fehlt bisher ein Basislehrbuch der Medizin für Ökonomen, also ein Buch, das medizinische Inhalte auf das für Gesundheitsökonomen relevante Maß begrenzt und dabei versucht, medizinische Maßnahmen im Zusammenhang mit Kostenbewertungen zu veranschaulichen.&nbsp;Das wesentliche Anliegen des vorliegenden Buches ist daher die Verbindung ärztlichen Denkens und Handelns mit ökonomischen Überlegungen, da der Dialog zwischen Ökonomen und Mediziner nur auf der Basis gemeinsamen Wissens effizient geführt werden kann.

Medizin für Ökonomen

Globalisation promised a world of open markets, shared prosperity and peace through trade. Instead, it has delivered a new battle for wealth and power.In All the Money in the World, The Times Economics Editor Mehreen Khan argues that mercantilism - the centuries-old belief that economic strength is the foundation of national power - is back. Trade is no longer just about efficiency or cheap goods. It is about dominance. It is about who makes the world's products, controls its resources, owns its technology, and sets the terms for everyone else.From China's record trade surpluses to Donald Trump's tariffs, from Europe's industrial anxiety to the race for chips, batteries and critical minerals, economics has become a frontline of great power conflict. Governments are no longer simply competing in the global market; they are trying to rig it in their favour.With deep insight, authority and historical sweep, Khan reveals how the world has moved from the triumph of free trade to the return of protectionism, economic coercion and geopolitical rivalry. She shows why trade imbalances matter, how dependency becomes a weapon and why the comforting certainties of the neoliberal age are breaking down.Urgent and eye-opening, All the Money in the World is an essential guide to the new era of economic warfare.

The New Battle for Global Wealth and Power

All the Money in the World

"Dr. Elisa Port saved my life. She is my North Star—a physician whose intelligence, judgment, and compassion I trust completely. The Breast Advice is the definitive guide for anyone seeking the very best information and care for their breast health." — Jill Martin, Emmy Award-winning TV personalityEverything you need to know about breast health and breast cancer in one place, essential advice you can trust from Mount Sinai’s Chief of Breast Surgery, Dr. Elisa Port, and her patients.Breast cancer is the most common cancer affecting women in the United States. There are 300,000 women diagnosed in the United States each year, and of all cancers women get, one in three will be breast. Everyone has been touched by breast cancer in some way – as the more than 4 million breast cancer survivors in the US can attest. With misinformation flooding us from chat forums to wellness influencers, where can we turn for the truth?The Breast Advice offers a trustworthy resource as you navigate assessing your risk of breast cancer, navigate screening and prevention, and treatment, dispelling myths and laying out the facts, including the latest innovations from AI to new screening techniques. Bringing in patients' wisdom together with her 25 years of experience as one of New York’s most celebrated specialists, Mount Sinai’s Chief of Breast Surgery Dr. Elisa Port has created a comprehensive guide to breast cancer risk, diagnosis, and treatment. Addressing: <ul><li>Lifestyle factors to prevent breast cancer</li><li>Risk assessment, screening, and testing—including the latest technology</li><li>Diagnosis—choosing a doctor, what to ask, how to manage hard news</li><li>Treatment—from radiation and chemotherapy to surgery and novel therapies</li><li>Top ten pieces of advice from patients who have been through it</li></ul> An essential resource for everyone with breasts, The Breast Advice will be passed around and relied upon for years to come."Say Dr. Elisa Port’s name in any crowded room in the New York area and you’re likely to find at least one adoring fan of Mount Sinai’s chief of breast surgery." — Town + Country

Everything you need to know about breast health and breast cancer in one place, essential advice you can trust from Mount Sinai’s Chief of Breast Surgery, Dr. Elisa Port, and her patients.Breast cancer is the most common cancer affecting women in the United States. There are 300,000 women diagnosed in the United States each year, and of all cancers women get, one in three will be breast. Everyone has been touched by breast cancer in some way – as the more than 4 million breast cancer survivors in the US can attest. With misinformation flooding us from chat forums to wellness influencers, where can we turn for the truth? The Breast Advice offers a trustworthy resource as you navigate assessing your risk of breast cancer, navigate screening and prevention, and treatment, dispelling myths and laying out the facts, including the latest innovations from AI to new screening techniques. Bringing in patients' wisdom together with her 25 years of experience as one of New York’s most celebrated specialists, Mount Sinai’s Chief of Breast Surgery Dr. Elisa Port has created a comprehensive guide to breast cancer risk, diagnosis, and treatment. Addressing: <ul><li>Lifestyle factors to prevent breast cancer</li><li>Risk assessment, screening, and testing—including the latest technology</li><li>Diagnosis—choosing a doctor, what to ask, how to manage hard news</li><li>Treatment—from radiation and chemotherapy to surgery and novel therapies</li><li>Top ten pieces of advice from patients who have been through it</li></ul> An essential resource for everyone with breasts, The Breast Advice will be passed around and relied upon for years to come.

All You Need to Know About Breast Health, Screening, and Treatment

The Breast Advice

'With Sisters in Yellow, [Kawakami] proves she is still the most exciting Japanese novelist at work today' The Times Deluxe Hardback edition From the International Booker Prize-Shortlisted author of Heaven and Breasts and Eggs Hana has nothing but she's hopeful. She's fifteen years old. She lives in a tiny apartment in a suburb of Tokyo with her young mother, a hostess at a local dive bar. They have no money, no security. Then Kimiko appears. Kimiko is older, a bright light in Hana's dark world. Together they set up Lemon, a bar that, despite its shabby setting and seedy clientele, becomes a haven for Hana. Suddenly Hana has a job she loves, friends to share her days with, and the glittering promise of money. She feels like a normal girl. She feels invincible. But in the narrow alleys of Sangenjaya, nothing is as it seems. Soon all of Hana's hope, her optimism, and her drive, will be tested to the limit . . . A story of enduring friendship and deep betrayal, Sisters in Yellow is a masterpiece of teenage dreams and adult cruelties that confirms Mieko Kawakami as one of the great writers of her generation.

Sisters in Yellow

The New York Times Bestseller A Financial Times Book of the Year 2025 A Guardian Book of the Year 2025A detailed guide to a revolution transforming human longevity -- a breakthrough moment in the history of human health care -- from one of the most respected medical researchers in the world.'Fascinating . . . expertly surveys the latest approaches to managing the diseases and decline associated with ageing.' Financial Times'Extraordinary . . . a blueprint for the future.' Siddhartha Mukherjee, author of The Emperor of All Maladies'A tour de force.' Venki Ramakrishnan, Nobel Laureate and author of Why We DieIn this breakthrough moment in the history of human health care, Super Agers is an evidenced-based guide to the revolution transforming human longevity. From his unique position as a leader overseeing millions in research funding, Dr Topol explains how you can benefit from new the treatments becoming available at a faster rate than ever, and the fundamental reasons - from semaglutides to AI - that we can be confident these breakthroughs will continue.More than a quarter of the adult population lives with two or more chronic diseases, with that figure increasing to over half in individuals aged 65 and older. Dr Topol explains the power of the new approaches to the worst chronic killers - diabetes/obesity, heart disease, cancer, and neurodegeneration-and how treatments can begin long before middle age, and even long after. In thirty years, we will have five times as many people at least one hundred years old and they will be healthier than ever because of the breakthroughs Super Agers describes.These remarkable discoveries are deeply inspiring about our human potential. We can now realistically see how we can make considerable headway for preventing age-related diseases and may one day be able to slow the body-wide aging process itself.'Imagine a world where diseases once thought incurable are treated, where we are healthier for longer. This future is getting close thanks to a radical convergence of AI and bioscience. In this gripping, vitally important and meticulously researched account, Eric Topol reveals the extraordinary breakthroughs that are transforming medicine-and our lives.' Mustafa Suleyman, author of The Coming Wave

An Evidence-Based Approach to Longevity

Super Agers

Corporatism and Neoliberalism in a Global Era

The World Economic Forum and COVID-19

Die Geschichte meines Körpers

Aua!

Leadership in Global Health outlines the essential leadership principles that transform promising health interventions into global movements, offering a timely and compelling blueprint for leaders seeking to drive lasting, scalable change.Grounded in decades of lessons from global health successes and failures, and illustrated through deeply analyzed, real-world case studies, the book reveals what happens when leadership meets coordinated action. These stories- from the eradication of smallpox and the large-scale delivery of malaria bed nets to the community-based innovations of Ethiopia's Health Extension Program and the lightning-fast COVID-19 vaccine rollout-show how leadership in global health is not one-size-fits-all, but rather dynamic, responsive, and deeply human. In an era where complex health challenges range from emerging pandemics to enduring inequities, the book centers the role of leadership-strategic, adaptive, and collaborative-as the critical engine for scaling health interventions, offering readers not only compelling narratives from the field, but also practical tools and reflections which give the book a forward-looking focus.Building to offer a roadmap for developing the next generation of global health leaders equipped to thrive in multi-sectoral, rapidly evolving environments, it will be essential reading for students, scholars, and practitioners across Global Health, Public Health, Leadership and Development Studies.

A Strategic Blueprint for Scalable Change

Leadership in Global Health

New Frontiers in Regional Science: Asian Perspectives

Incredible interest has been focused on digital transformation (DX) to solve a wide variety of worldwide challenges as impediments to sustainable development goals. This book provides theoretical frameworks of DX sustained by IoX (Internet of Everything) and data science and several topics associated with DX applications typically in the fields of human health and natural environments. The book will facilitate the reader’s acquisition of informatics literacy with relevance to the rapidly changed world by developing digital technologies.

Fundamentals and Perspectives Beyond Generative AI

Digital Transformation for Humans and Nature

Pharmanomics

Weitere Titel zum Thema